Medicines

This section of the website provides information on the regulation of medicines for human use in the European Union (EU). It particularly concerns the centralised procedure, where the European Medicines Agency (EMA) plays a key role.

Zydelig

active substance 1 / active substance 2 / active substance 3

  • Procedure started
  • Under evaluation
  • PRAC recommendation
  • CHMP opinion
  • European Commission final decision
Authorised
This medicine is authorised for use in the European Union
Patient safety
Patient safety informations

A transfer of the orphan designation is the procedure by which the orphan designation is transferred from the currently approved sponsor (orphan designation holder) to a new sponsor which is a different person/legal entity.

Overview

Related documents

Related links

Add your rating
Average